HCV Genotype 1b, 170 a.a.

Hepatitis C Virus Nucleocapsid (core) Genotype-1b, 170 a.a Recombinant
Cat. No.
BT12935
Source
Escherichia Coli.
Synonyms
Appearance
Sterile filtered colorless solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant HCV Core genotype 1b produced in E.Coli containing 170 amino acids and purified by proprietary chromatographic techniques.

Product Specs

Introduction
Hepatitis C virus (HCV) is a small, enveloped virus with a single-stranded RNA genome. It belongs to the Flaviviridae family and has a diameter of approximately 50 nanometers. HCV exhibits a high rate of replication, producing roughly one trillion viral particles daily within an infected individual. The virus's RNA polymerase lacks proofreading ability, leading to a remarkably high mutation rate. This characteristic contributes to HCV's ability to evade the host's immune system. HCV is classified into six genotypes (1-6), each with distinct subtypes. The prevalence and distribution of these genotypes vary worldwide. Genotype determination is crucial for clinical management, as it influences the selection and duration of interferon-based therapy. Genotypes 1 and 4 respond less favorably to interferon-based treatment compared to genotypes 2, 3, 5, and 6.
Description
This product consists of the recombinant HCV Core protein derived from genotype 1b. It is produced in E. coli and encompasses 170 amino acids. The protein undergoes purification using proprietary chromatographic techniques.
Physical Appearance
The product appears as a clear and colorless solution that has been sterilized by filtration.
Formulation
The product is provided as a sterile-filtered solution in 1x phosphate-buffered saline (PBS) containing 25mM arginine.
Stability
For optimal storage, the product should be kept at 4 degrees Celsius if the entire vial will be used within 2-4 weeks. For extended storage, it is recommended to freeze the product at -20 degrees Celsius. The addition of a carrier protein, such as 0.1% human serum albumin (HSA) or bovine serum albumin (BSA), is advisable for long-term storage. Repeated freezing and thawing of the product should be avoided.
Purity
Analysis by SDS-PAGE indicates that the purity of the product is greater than 95%.
Source
Escherichia Coli.
Amino Acid Sequence

MKETAAAKFERQHMDSPDLGTLVPRGSMADIGSSTNPKPQRKTKRNTNRRPQDV
KFPGGGQIVGGVYLLPRRGPRLGVRATRKTSERSQPRGWRQPIPKARRPEGRAW
AQPGYPWPLYGNEGLGWAGWLLSPRGSRPSWGPTDPRRRSRNLGKVIDTLTCGF
ADLMGYIPLVGAPLGGAARALAHGVRVLEDGVNYATGNLPVDKLAAALEHHHHHH*

Product Science Overview

Introduction

Hepatitis C Virus (HCV) is a significant global health concern, affecting millions of individuals worldwide. The virus is classified into seven genotypes, with genotype 1 being the most prevalent and associated with severe liver diseases such as cirrhosis and hepatocellular carcinoma . The nucleocapsid (core) protein of HCV plays a crucial role in the virus’s life cycle, including the assembly and packaging of the viral RNA genome .

Structure and Function

The HCV core protein is a highly conserved structural protein that forms the viral nucleocapsid. It is composed of 170 amino acids and is responsible for encapsulating the viral RNA . The core protein also interacts with various host cell factors, influencing viral replication and pathogenesis . The recombinant form of the HCV core protein, particularly from genotype 1b, has been extensively studied for its role in the virus’s life cycle and its potential as a target for therapeutic interventions .

Genotype 1b

Genotype 1b is one of the most common and clinically significant genotypes of HCV. It is associated with a higher risk of developing severe liver diseases and has been found to be less responsive to certain antiviral treatments compared to other genotypes . The core protein of genotype 1b has unique structural and functional properties that contribute to its pathogenicity and persistence in the host .

Recombinant Core Protein

The recombinant form of the HCV core protein is produced using various expression systems, such as bacterial, yeast, and mammalian cells . This recombinant protein is used in research to study the virus’s structure, function, and interactions with host cells. It also serves as a valuable tool in the development of diagnostic assays and potential vaccines .

Research and Applications

Research on the recombinant HCV core protein has provided significant insights into the virus’s biology and pathogenesis. Studies have shown that the core protein can modulate host immune responses, influence cell signaling pathways, and interact with other viral and host proteins . These findings have implications for the development of novel therapeutic strategies and vaccines targeting the core protein .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.